Towers Watson acquires Extend Health

Towers Watson (NYSE, NASDAQ: TW), a leading global professional services company, today announced the completion of its acquisition of Extend Health, Inc., which operates the largest private Medicare exchange in the United States. The acquisition enables Towers Watson to provide employers with health care solutions that combine specialized retiree medical transition consulting with the choice and cost advantages of individual Medicare plans purchased on a private exchange.    

"Extend Health's proven infrastructure and scalable exchange platform bring a dynamic new offering to Towers Watson," said John Haley, CEO of Towers Watson. "Our market-leading solutions will provide our clients with an immediate and unprecedented opportunity to deliver retiree medical benefit packages in a new and cost-effective way."

Extend Health will operate as a new business segment called Exchange Solutions within Towers Watson alongside the existing segments of Benefits, Talent and Rewards, and Risk and Financial Services. Bryce Williams, co-founder and CEO of Extend Health, will lead the new segment.

"We are excited to join Towers Watson at this crucial time when many companies are rethinking their retiree health benefits," said Williams. "We look forward to meeting the evolving needs of employers and retirees by building on both organizations' deep commitment to innovative, proven solutions and unwavering client service."

Source:

Towers Watson    

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Medicare Advantage leads to lower cancer drug costs in colorectal cancer